| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Gri Bio, Inc. (GRI) has 7 insiders with recent SEC Form 4 filings, including 6 buys and 0 sells. GRI is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 103.1K | $231.9K | - | |
| CFO | 43.2K | $97.2K | - | |
| Other | 43.2K | $97.2K | - | |
| Dir | 39.9K | $89.8K | - | |
| Dir | 23.6K | $53.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 4, 2021 | Kelly Leanne M. | Chief Financial Officer | Buy | 6,250 | $4.03 | $25,174.89 | +74.4% | +97.8% | -86.5% | |
| May 26, 2021 | Payne Joseph E | Director | Buy | 17,500 | $4.10 | $71,795.00 | +163.6% | +2.5% | -87.3% | |
| Feb 12, 2021 | Baker David Charles | Chief Executive Officer | Buy | 1,000 | $8.00 | $8,000.00 | +12.8% | - | - |